Amy Lin

8.6k total citations · 1 hit paper
23 papers, 6.6k citations indexed

About

Amy Lin is a scholar working on Molecular Biology, Hepatology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Amy Lin has authored 23 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Hepatology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Amy Lin's work include Neuroscience and Neuropharmacology Research (7 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Amy Lin is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Amy Lin collaborates with scholars based in United States, Spain and Switzerland. Amy Lin's co-authors include Mitchell L. Shiffman, M. Diago, K. Rajender Reddy, Coleman I. Smith, Michael Fried, Dieter Häussinger, Antonio Craxı̀, George Marinos, Giampiero Carosi and Fernando Lopes Gonçales and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Amy Lin

23 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

2002 5.1k citations Michael Fried, Mitchell L. Shiffman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Lin United States	15	5.7k	5.0k	722	620	609	23	6.6k
David Chien United States	33	2.4k 0.4×	2.2k 0.4×	213 0.3×	703 1.1×	266 0.4×	72	4.8k
Jason S. Simon United States	23	2.2k 0.4×	2.0k 0.4×	289 0.4×	978 1.6×	419 0.7×	59	4.8k
Andreas E. Kremer Germany	32	1.2k 0.2×	895 0.2×	155 0.2×	876 1.4×	474 0.8×	150	3.9k
Hans‐Peter Fischer Germany	36	624 0.1×	902 0.2×	304 0.4×	816 1.3×	156 0.3×	137	3.6k
Stephan Böhm Germany	30	623 0.1×	983 0.2×	152 0.2×	1.2k 1.9×	70 0.1×	73	3.8k
Kui Qian Finland	15	997 0.2×	988 0.2×	123 0.2×	500 0.8×	203 0.3×	24	1.9k
Kiyohiro Ando Japan	25	725 0.1×	1.1k 0.2×	209 0.3×	1.2k 1.9×	74 0.1×	59	3.1k
Christoph J. Auernhammer Germany	40	285 0.0×	2.2k 0.4×	92 0.1×	845 1.4×	141 0.2×	137	5.4k
William A. Rudert United States	31	255 0.0×	470 0.1×	97 0.1×	854 1.4×	125 0.2×	70	4.6k
Bertrand Saunier France	18	249 0.0×	292 0.1×	250 0.3×	601 1.0×	49 0.1×	26	1.5k

Countries citing papers authored by Amy Lin

Since Specialization

Citations

This map shows the geographic impact of Amy Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lin more than expected).

Fields of papers citing papers by Amy Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lin. The network helps show where Amy Lin may publish in the future.

Co-authorship network of co-authors of Amy Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Lin. A scholar is included among the top collaborators of Amy Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Lin. Amy Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Amy, Suzanne Claxton, Helen R. Flynn, et al.. (2018). Chemical genetic identification of GAK substrates reveals its role in regulating Na⁺/K⁺-ATPase. Life Science Alliance. 1(6). e201800118–e201800118. 7 indexed citations

Xiao, Peng, Qing Li, Chang Pan, et al.. (2018). Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot auto-inhibition and activation. Journal of Biological Chemistry. 293(42). 16226–16241. 2 indexed citations

Yang, Zhao, Fan Yang, Daolai Zhang, et al.. (2017). Phosphorylation of G Protein-Coupled Receptors: From the Barcode Hypothesis to the Flute Model. Molecular Pharmacology. 92(3). 201–210. 102 indexed citations

Ge, Lin, Kangshuai Li, Peng Xiao, et al.. (2016). Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase. Bioorganic & Medicinal Chemistry Letters. 26(19). 4795–4798. 4 indexed citations

Lin, Amy & Heng‐Ye Man. (2014). Endocytic Adaptor Epidermal Growth Factor Receptor Substrate 15 (Eps15) Is Involved in the Trafficking of Ubiquitinated α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors. Journal of Biological Chemistry. 289(35). 24652–24664. 21 indexed citations

Dhonnchadha, Bríd Á. Nic, Neha Shrestha, Amy Lin, et al.. (2012). Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behavioural Brain Research. 234(1). 100–106. 18 indexed citations

Dhonnchadha, Bríd Á. Nic, Amy Lin, Kimberly A. Leite‐Morris, et al.. (2012). Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning. Behavioural Brain Research. 238. 119–123. 17 indexed citations

Zeuzem, Stefan, M. Rodríguez‐Torres, K. Rajender Reddy, et al.. (2012). Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa‐2a/ribavirin. Journal of Viral Hepatitis. 19(11). 766–774. 10 indexed citations

Lin, Amy, Qingming Hou, Larissa A. Jarzylo, et al.. (2011). Nedd4‐mediated AMPA receptor ubiquitination regulates receptor turnover and trafficking. Journal of Neurochemistry. 119(1). 27–39. 135 indexed citations

10.

Sarrazin, Christoph, Mitchell L. Shiffman, Stephanos J. Hadziyannis, et al.. (2010). Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy. Journal of Hepatology. 52(6). 832–838. 36 indexed citations

11.

Swain, Mark G., Ming–Yang Lai, Mitchell L. Shiffman, et al.. (2010). A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin. Gastroenterology. 139(5). 1593–1601. 231 indexed citations

12.

Zhang, Dawei, Qingming Hou, Min Wang, et al.. (2009). Na,K-ATPase Activity Regulates AMPA Receptor Turnover through Proteasome-Mediated Proteolysis. Journal of Neuroscience. 29(14). 4498–4511. 98 indexed citations

13.

Oberlander, Joseph G., Amy Lin, Heng‐Ye Man, & Mary S. Erskine. (2008). AMPA receptors in the medial amygdala are critical for establishing a neuroendocrine memory in the female rat. European Journal of Neuroscience. 29(1). 146–160. 3 indexed citations

14.

Shiffman, Mitchell L., Fredy Suter, Bruce R. Bacon, et al.. (2007). Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3. New England Journal of Medicine. 357(2). 124–134. 384 indexed citations

15.

Marcellin, Patrick, S. Hadziyannis, Thomas Berg, et al.. (2007). [613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRIN. Journal of Hepatology. 46. S231–S232. 10 indexed citations

16.

Willems, B., S. Hadziyannis, Tim Morgan, et al.. (2007). [8] SHOULD TREATMENT WITH PEGINTERFERON PLUS RIBAVIRIN BE INTENSIFIED IN PATIENTS WITH HCV GENOTYPE 2/3 WITHOUT A RAPID VIROLOGICAL RESPONSE?. Journal of Hepatology. 46. S6–S6. 32 indexed citations

17.

Lin, Amy & Ellen M. Carpenter. (2003). Hoxa10 and Hoxd10 coordinately regulate lumbar motor neuron patterning. Journal of Neurobiology. 56(4). 328–337. 38 indexed citations

18.

Fried, Michael, Mitchell L. Shiffman, K. Rajender Reddy, et al.. (2002). Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection. New England Journal of Medicine. 347(13). 975–982. 5092 indexed citations breakdown →

19.

Reddy, K. Rajender, Teresa L. Wright, Paul J. Pockros, et al.. (2001). Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C. Hepatology. 33(2). 433–438. 284 indexed citations

20.

Wills, Robert J., et al.. (1987). Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease. Clinical Pharmacology & Therapeutics. 42(4). 449–454. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact